Skip to main content
Equibles

Allianz Asset Management GmbH

Position in EXEL — Exelixis, Inc.

CIK 1535323 MUNICH, 2M
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$36,251,640
-$4,689,050 QoQ
Shares Held
666,268
-30.2% QoQ
Ownership
0.269%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 23% Shared 0% None 77%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $783,743,061 across 80 Biotechnology names. EXEL ranks #4 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 380,618 $237,330,545
2 JAZZ
Jazz Pharmaceuticals plc
 545,071 $131,345,757
3 MRNA
Moderna, Inc.
 984,497 $68,944,324
4 EXEL
Exelixis, Inc.
This page 		666,268 $36,251,640
5 INCY
Incyte Corp
 229,921 $26,063,844
6 BMRN
Biomarin Pharmaceutical Inc
 418,602 $23,952,406
7
177,000 $23,493,210
8 FTRE
Fortrea Holdings Inc.
 1,141,537 $19,862,743

All Filings in EXEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,251,640 666,268
2026-03-31 $40,940,690 954,551
2025-12-31 $63,972,075 1,459,550
2025-09-30 $101,719,750 2,462,948
2025-06-30 $42,864,625 972,428
2025-03-31 $19,176,543 519,408
2024-12-31 $3,186,310 95,685
2024-09-30 $5,075,197 195,576
2024-06-30 $4,611,158 205,214
2024-03-31 $4,112,693 173,312
2023-12-31 $2,992,128 124,724
2023-09-30 $2,425,393 111,002
2023-06-30 $2,317,297 121,261
2023-03-31 $27,219,981 1,402,369
2022-12-31 $22,469,055 1,400,814
2022-09-30 $24,788,903 1,580,925
2022-06-30 $31,557,123 1,515,712
2022-03-31 $28,248,542 1,246,076
2021-12-31 $20,487,730 1,120,773
2021-09-30 $23,564,187 1,114,673
2021-06-30 $7,275,246 399,300
2020-09-30 $981,423 40,140
2020-06-30 $2,940,578 123,866
2020-03-31 $1,077,627 62,580